Related Experiment Video
Updated: Aug 16, 2025

Mechanical Stimulation-induced Calcium Wave Propagation in Cell Monolayers: The Example of Bovine Corneal Endothelial Cells
Published on: July 16, 2013
Hypertensive Nephropathy: Unveiling the Possible Involvement of Hemichannels and Pannexons
Claudia M Lucero1, Juan Prieto-Villalobos2, Lucas Marambio-Ruiz1
1Instituto de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, El Llano Subercaseaux #2801, Santiago 8910060, Chile.
Insights
Hypertension damages kidneys by activating mesangial cells and disrupting calcium signaling. Angiotensin II (AngII) and channel activity may create a harmful cycle leading to kidney disease.
Area of Science:
- Nephrology
- Cardiovascular Research
- Cellular Biology
Background:
- Hypertension is a major risk factor for chronic cardiovascular diseases, notably hypertensive nephropathy.
- In hypertensive nephropathy, glomerular mesangial cells (MCs) are damaged and activated, releasing vasoactive and proinflammatory factors.
- Intracellular calcium ([Ca2+]i) signaling dysfunction, particularly via AT1 receptor activation by angiotensin II (AngII), is central to renal damage and inflammation.
Purpose of the Study:
- To review the role of intracellular calcium ([Ca2+]i) signaling in hypertensive nephropathy.
- To explore the proposed mechanism involving connexin/pannexin channels, ATP release, and purinergic receptors in AngII-mediated kidney damage.
- To highlight the potential feed-forward mechanism contributing to renal pathology.
Main Methods:
- Literature review focusing on cellular and molecular mechanisms of hypertensive nephropathy.
- Analysis of the role of intracellular calcium ([Ca2+]i) signaling pathways.
- Examination of the involvement of hemichannels, pannexons, and purinergic signaling.
Main Results:
- Hypertension-induced MC activation leads to the release of vasoactive and proinflammatory agents.
- [Ca2+]i signaling deregulation exacerbates cell damage, fibrosis, reduces renal blood flow, and impairs the glomerular filtration barrier.
- Connexin and pannexin channels, regulated by [Ca2+]i, are implicated in AngII-mediated renal damage.
Conclusions:
- AngII-mediated activation of AT1 receptors contributes significantly to hypertensive nephropathy pathogenesis via [Ca2+]i signaling.
- The opening of connexin/pannexin channels by AngII may induce ATP release, activating purinergic receptors and causing calcium overload.
- This process represents a potential feed-forward mechanism driving progressive kidney damage in hypertension.
Abstract:
Hypertension is one of the most common risk factors for developing chronic cardiovascular diseases, including hypertensive nephropathy. Within the glomerulus, hypertension causes damage and activation of mesangial cells (MCs), eliciting the production of large amounts of vasoactive and proinflammatory agents. Accordingly, the activation of AT1 receptors by the vasoactive molecule angiotensin II (AngII) contributes to the pathogenesis of renal damage, which is mediated mostly by the dysfunction of intracellular Ca2+ ([Ca2+]i) signaling. Similarly, inflammation entails complex processes, where [Ca2+]i also play crucial roles. Deregulation of this second messenger increases cell damage and promotes fibrosis, reduces renal blood flow, and impairs the glomerular filtration barrier. In vertebrates, [Ca2+]i signaling depends, in part, on the activity of two families of large-pore channels: hemichannels and pannexons. Interestingly, the opening of these channels depends on [Ca2+]i signaling. In this review, we propose that the opening of channels formed by connexins and/or pannexins mediated by AngII induces the ATP release to the extracellular media, with the subsequent activation of purinergic receptors. This process could elicit Ca2+ overload and constitute a feed-forward mechanism, leading to kidney damage.
Related Concept Videos
Hypertension II: Pathophysiology
Heart Failure II: Pathophysiology
Antihypertensive Drugs: Action of Calcium Channel Blockers
Hypertension and Regulation of Blood Pressure
Pathophysiology of Heart Failure
Aquaporins

